Leadership Overview
Ipca Laboratories has 9 executives leading key functions including medical affairs, clinical research, API research, generics, international marketing, manufacturing, and quality assurance.
Driven by a commitment to global health, Ipca Laboratories is dedicated to providing high-quality pharmaceutical products across diverse therapeutic areas, impacting patient well-being worldwide.
Driven by a commitment to global health, Ipca Laboratories is dedicated to providing high-quality pharmaceutical products across diverse therapeutic areas, impacting patient well-being worldwide.
Leadership Roles at Ipca Laboratories
Anil Pareek - President, Medical Affairs & Clinical Research
Anil Pareek, the President, Medical Affairs & Clinical Research at Ipca Laboratories, directs the strategic development and execution of all medical affairs initiatives. This leadership role involves overseeing clinical research programs, ensuring compliance with global regulatory standards, and fostering scientific exchange with healthcare professionals. Pareek's oversight extends to the generation and dissemination of clinical data, supporting the company's product portfolio and pipeline development. The scope of this position includes managing medical information services and pharmacovigilance activities, ensuring patient safety and product integrity. By driving evidence-based medical strategies, Anil Pareek contributes significantly to Ipca Laboratories' reputation as a trusted pharmaceutical provider, enhancing its market presence through robust scientific validation and communication across key global markets.
Saidutta Nanda - President
Saidutta Nanda, the President at Ipca Laboratories, spearheads critical operational functions that underpin the company's extensive manufacturing and marketing capabilities. This executive leadership position involves driving efficiency and innovation across multiple business units, ensuring seamless integration of research, development, and production. Nanda's responsibilities encompass optimizing supply chain logistics and enhancing manufacturing processes to meet stringent quality and volume demands. The role requires close collaboration with other senior leaders to align operational strategies with the company's overarching business objectives and market expansion plans. By focusing on operational excellence, Saidutta Nanda ensures that Ipca Laboratories maintains its competitive edge in delivering a broad range of pharmaceutical products, supporting the company's mission to provide accessible healthcare solutions globally.
N.A. Vekariya - President, Api Research & Development
N.A. Vekariya, the President, Api Research & Development at Ipca Laboratories, leads the critical function of developing and optimizing Active Pharmaceutical Ingredients (APIs). This role is central to Ipca Laboratories' integrated model, focusing on innovation in API synthesis, process development, and scale-up. Vekariya's team is responsible for creating cost-effective and high-purity APIs that form the foundation of the company's diverse formulation portfolio. The scope includes exploring novel chemical pathways and improving existing manufacturing processes to enhance yield and reduce environmental impact. By driving advancements in API R&D, N.A. Vekariya ensures a robust and proprietary supply of essential pharmaceutical components, directly supporting the company's global market competitiveness and its commitment to producing high-quality medicines.
Kavita Sehwani - President - Generics
Kavita Sehwani, the President - Generics at Ipca Laboratories, directs the strategic growth and market penetration of the company's generic pharmaceutical offerings. This leadership position involves overseeing the entire lifecycle of generic products, from development and regulatory approval to marketing and sales across various international territories. Sehwani's focus is on expanding the generics portfolio, ensuring competitive pricing, and maintaining high standards of quality and efficacy. The role requires deep market insight to identify opportunities and navigate complex regulatory landscapes in different regions. By driving the success of the generics division, Kavita Sehwani plays a pivotal role in making essential medicines more accessible and affordable to a wider patient population worldwide, reinforcing Ipca Laboratories' global healthcare mission.
Murali Sarma - President
Murali Sarma, the President at Ipca Laboratories, oversees key strategic operations that contribute to the company's sustained growth and market leadership. This executive position involves driving cross-functional initiatives and ensuring alignment across various departments to achieve corporate objectives. Sarma's responsibilities include fostering a culture of innovation and operational excellence, managing complex projects, and contributing to long-term business planning. The role demands a comprehensive understanding of the pharmaceutical industry landscape, including market dynamics, regulatory environments, and competitive pressures. By providing strategic direction and operational oversight, Murali Sarma ensures that Ipca Laboratories effectively navigates challenges and capitalizes on opportunities, reinforcing its position as a significant player in the global pharmaceutical sector.
Hitesh Maheshwari - President, Research & Development (Formulations)
Hitesh Maheshwari, the President, Research & Development (Formulations) at Ipca Laboratories, leads the innovation engine for the company's finished dosage forms. This critical role focuses on developing novel and improved pharmaceutical formulations that meet diverse therapeutic needs and patient requirements. Maheshwari's team is responsible for the entire R&D process, from conceptualization and pre-clinical studies to formulation optimization and technology transfer for commercial manufacturing. The scope includes ensuring that all developed formulations adhere to the highest standards of quality, safety, and efficacy, while also considering market accessibility and patient compliance. By driving cutting-edge formulation research, Hitesh Maheshwari significantly contributes to Ipca Laboratories' product pipeline and its ability to offer advanced healthcare solutions globally.
Shashil Mendonsa - Marketing President, International
Shashil Mendonsa, the Marketing President, International at Ipca Laboratories, directs the global marketing strategies and commercial operations for the company's extensive product portfolio. This leadership role involves identifying and capitalizing on international market opportunities, developing tailored marketing campaigns, and driving sales growth across diverse geographic regions. Mendonsa's responsibilities include building strong brand presence, managing distribution networks, and ensuring effective market penetration for both branded and generic pharmaceuticals. The scope encompasses understanding and adapting to varied regulatory environments and cultural nuances in different countries. By leading international marketing efforts, Shashil Mendonsa plays a crucial part in expanding Ipca Laboratories' global footprint and enhancing its reputation as a leading pharmaceutical provider worldwide.
Shailesh Laul - President, Manufacturing Operations
Shailesh Laul, the President, Manufacturing Operations at Ipca Laboratories, oversees the company's extensive production facilities and ensures the efficient, high-quality manufacturing of pharmaceutical products. This critical role involves managing all aspects of the manufacturing process, from raw material sourcing and production planning to quality control and timely delivery. Laul's responsibilities include implementing advanced manufacturing technologies, optimizing operational workflows, and ensuring strict adherence to global Good Manufacturing Practices (GMP) and regulatory requirements. The scope extends to managing production capacity, driving cost efficiencies, and maintaining robust supply chain integrity across all manufacturing sites. By ensuring operational excellence in manufacturing, Shailesh Laul directly supports Ipca Laboratories' ability to meet global demand for its diverse range of medicines.
Sanjay Kapadia - President, Corporate Quality
Sanjay Kapadia, the President, Corporate Quality at Ipca Laboratories, leads the comprehensive quality assurance and quality control functions across the organization. This executive position is paramount in ensuring that all products manufactured by Ipca Laboratories meet the highest international standards for safety, efficacy, and purity. Kapadia's responsibilities include developing and implementing robust quality management systems, overseeing regulatory compliance, and driving continuous improvement in quality processes throughout the product lifecycle. The scope involves rigorous auditing, risk management, and ensuring adherence to global regulatory guidelines from agencies worldwide. By championing a culture of quality excellence, Sanjay Kapadia safeguards Ipca Laboratories' reputation and ensures the consistent delivery of reliable pharmaceutical products to patients globally.
Explore Leadership Teams in Manufacturing
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership GA
ZP
AH
DL
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and finished formulations. Its products address multiple therapeutic areas, including cardiovascular disease, pulmonary and kidney conditions, neurological and psychiatric disorders, HIV/AIDS, respiratory and asthma care, oncology, diabetes and metabolic disorders, infectious diseases, critical care, women’s health, ophthalmology, and child health. In addition to its core pharmaceutical portfolio, Cipla is active in consumer healthcare, biosimilars, and specialty medicine businesses. Founded in 1935, Cipla has grown into a major global healthcare player.
Company Leadership GJ
LV
LB
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
Company Leadership CD
CL
CW
QW
Synokem Pharmaceuticals Ltd is a rising pharmaceutical organization established in 1983, specializing in contract manufacturing, ethical marketing, exports, and institutional supplies. The company aims to provide quality pharmaceutical products that are affordable to all sections of society, with a vision to become a world-class manufacturer. Synokem is committed to enhancing its market share through strategic alliances and collaborations, particularly in the international business sector. With a focus on research and development, the company is dedicated to achieving significant growth and establishing itself as an industry leader.
Company Leadership RM
RA
PS
SS
Frequently Asked Questions Regarding Ipca Laboratories Top Executives and Leadership Team
